about
Effects of bradykinin on coronary blood flow and vasomotion in transplant patients.Predictors of ventricular remodelling in patients with reperfused acute myocardial infarction and left ventricular dysfunction candidates for bone marrow cell therapy: insights from the BONAMI trial.Coronary microcirculation and cardiovascular pathology.Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trialGene therapy in heart disease.Registry of transcatheter aortic-valve implantation in high-risk patients.Sustained quality of life improvement after intracoronary injection of autologous bone marrow cells in the setting of acute myocardial infarction: results from the BONAMI trial.Myocardial Gene Expression Profiling to Predict and Identify Cardiac Allograft Acute Cellular Rejection: The GET-Study.[15 years of coronary angioplasty: focus on the different techniques].Apoptosis in pressure overload-induced heart hypertrophy in the rat.1-year outcome of TRIAS HR (TRI-stent adjudication study-high risk of restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents.Time-Course Reduction in Patient Exposure to Radiation From Coronary Interventional Procedures: The Greater Paris Area Percutaneous Coronary Intervention Registry.Massive Accumulation of Myofibroblasts in the Critical Isthmus Is Associated With Ventricular Tachycardia Inducibility in Post-Infarct Swine Heart.Percutaneous occlusion of the left atrial appendage: An expert consensus statement.Statin therapy and low-density lipoprotein cholesterol reduction in HIV-infected individuals after acute coronary syndrome: Results from the PACS-HIV lipids substudy.Coronary Procedures After TAVI With the Self-Expanding Aortic Bioprosthesis Medtronic CoreValve™, Not an Easy Matter.Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery.Pulmonary hemodynamic responses to inhaled NO in chronic heart failure depend on PDE5 G(-1142)T polymorphism.Outcome and incidence of appropriate implantable cardioverter-defibrillator therapy in patients with cardiac amyloidosis.Impact of QRS Duration on Decision of Early Removal of Pacing Catheter After Transcatheter Aortic Valve Replacement With CoreValve Device.EWOLUTION: Design of a registry to evaluate real-world clinical outcomes in patients with AF and high stroke risk-treated with the WATCHMAN left atrial appendage closure technology.Registry on acute cardiovascular events during endurance running races: the prospective RACE Paris registry.Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis.Preliminary report on AED deployment on the entire Air France commercial fleet: a joint venture with Paris XII University Training Programme.Magnetic resonance imaging of targeted catheter-based implantation of myogenic precursor cells into infarcted left ventricular myocardium.close: Closure of patent foramen ovale, oral anticoagulants or antiplatelet therapy to prevent stroke recurrence: Study design.Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety.Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?Baseline Characteristics and Prognostic Implications of Pre-Existing and New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Implantation: Results From the FRANCE-2 Registry.Outcomes following pacemaker implantation after transcatheter aortic valve implantation with CoreValve(®) devices: Results from the FRANCE 2 Registry.Comparison of Outcome of Transcatheter Aortic Valve Implantation With Versus Without Previous Coronary Artery Bypass Grafting (from the FRANCE 2 Registry).Alterations in beta adrenergic and muscarinic receptors in aged rat heart. Effects of chronic administration of propranolol and atropine.Role of drug eluting stents in diabetic patients.Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosisEffect of transcatheter (via femoral artery) aortic valve implantation on the platelet count and its consequences.Prognostic value of QRS duration after transcatheter aortic valve implantation for aortic stenosis using the CoreValve.A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial).Effect of local anesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation.Cardiac modulations of ANG II receptor expression in rats with hypoxic pulmonary hypertension.Is multidetector computed tomography a suitable alternative to MR imaging for the assessment of myocardial necrosis after alcohol septal ablation?
P50
Q30870321-C5899F7F-CB8B-40D6-A0DE-6AB836E2CC55Q33661061-EB00721D-3CFF-47AD-8FF7-7E0EE34DC5B2Q33754482-3774944B-3273-4808-988C-D25ED1AB14C1Q33762062-16E1130F-5BFC-4E90-B27F-F889B43D8081Q34233852-216B89E8-3668-41F5-852D-C457CBF1B617Q34637935-CCBA497B-9769-4A5A-B831-24FED6F40DFBQ36083241-BF096EB9-6396-4687-8A15-17A036EFF850Q36206861-942E8720-5A6E-4809-AB43-2C741581128CQ36803567-F33E0E51-5D2E-4C5C-B17A-6406C807F32BQ37356640-EE3914BB-2907-4D62-809B-E3BB1B960B35Q37919640-50EF5FF2-9520-4357-94F1-249DC7992821Q38628177-F19F8B12-DEFE-4405-8379-D50ECC048CE4Q38645319-F911F5F8-B97B-4213-980E-DC8CD5F6698EQ38661977-1ADE436F-B574-46B3-A027-649767EF9693Q38912590-6DB8EDCF-E823-4357-A6B2-035DAA9FB559Q39025549-71412D7E-BE9D-4FF3-9637-D9DC585AD709Q39340200-2F236862-C69C-4524-9B3A-5ED53B9160E4Q39385171-1B0B57C7-320B-4DDE-A379-5636568A9836Q39499997-84FFF75A-7B8F-4C72-BED1-CA53B052C9ADQ40130928-4513F121-73FA-4642-8E13-56DFC8BF0187Q40156592-DD90A97F-F23E-4F14-AD33-6BD48D40A846Q40160685-9F88D63A-70C9-4815-B0A4-E4778E7133B4Q40279526-D2B8B000-997B-48DF-97D8-B27F3D00983EQ40469903-C4BE16A0-6084-42C6-9AFE-4DDB3F3BC314Q40586273-95DC013E-1CBE-46F6-8081-65950526FAFAQ40811767-E9430728-F145-4FE4-9D18-20BEDD0D6E79Q40860125-F89301C7-6851-4AFD-AF9D-D0194B0173A3Q40891378-2B7F1579-2EAF-4629-BC9F-E1A8DADFA8D8Q41444347-CCE22717-5068-4F8B-9C6B-E28B6D895B52Q41602235-66FD7D47-0E1F-4620-B899-16286334F1F8Q41672164-EFE47E08-0287-41FB-9413-6FA2FAEFF24CQ42027199-9E67FC07-0B04-4232-B4E9-AAF0FA222D51Q42831869-4ACED40A-8A21-4434-B276-929587BE495DQ42832297-DD104EC0-86ED-408C-988E-109436AF7F26Q43622656-FE2CE309-B18D-4D96-99A0-E0EE35E7055CQ43753638-1C37DC10-9550-489F-9425-886E03D504AEQ43904132-D8ED63F6-64C4-4F61-91D5-FED98DBA8476Q43979442-4A718444-9519-4F9B-9BB3-20EB60E3DE3AQ44068511-E9CB1751-D9C2-47B4-B679-106975EA9157Q44106863-641C614F-A7DD-4A36-A2C9-F02857234AC1
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Emmanuel Teiger
@ast
Emmanuel Teiger
@en
Emmanuel Teiger
@es
Emmanuel Teiger
@nl
type
label
Emmanuel Teiger
@ast
Emmanuel Teiger
@en
Emmanuel Teiger
@es
Emmanuel Teiger
@nl
prefLabel
Emmanuel Teiger
@ast
Emmanuel Teiger
@en
Emmanuel Teiger
@es
Emmanuel Teiger
@nl
P106
P31
P496
0000-0001-7515-4344